Analyst & Firm | Company | Price | Rating & Price Target | Upside / Downside | Success Rate | Average Return | Action | Date | Article |
---|---|---|---|---|---|---|---|---|---|
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $62→$63 | ― | 12.80% | Assigned | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $166→$160 | ― | 10.30% | Assigned | ||||
Radcom | BUY $16 | ― | -2.30% | Reiterated | Radcom's Strategic Vision and Innovation Drive 'Buy' Recommendation | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $91 | ― | 6.00% | Upgraded | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $41 | ― | 6.00% | Upgraded | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $400→$379 | ― | 6.00% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $34 | ― | 30.90% | Assigned | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $270 | ― | 7.50% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $12 | ― | 2.30% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $18→$21 | ― | 0.20% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $20 | ― | 0.20% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $5 | ― | 0.20% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $17 | ― | 2.30% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $15→$17 | ― | 2.30% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $250 | ― | 13.20% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $115 | ― | 13.60% | Upgraded | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | SELL $54→$95 | ― | 1.00% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $70→$80 | ― | 1.00% | Reiterated | ||||
Zai Lab | BUY $29 | ― | -12.60% | Reiterated | Bank of America Securities Sticks to Its Buy Rating for Zai Lab (ZLAB) | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $7.5→$9 | ― | 1.00% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $126→$112 | ― | 17.70% | Downgraded | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | SELL $176→$166 | ― | 0.80% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $50→$58 | ― | 0.80% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $164 | ― | 6.00% | Reiterated | ||||
Lululemon Athletica | HOLD $340 | ― | -5.20% | Reiterated | Piper Sandler Keeps Their Hold Rating on Lululemon Athletica (LULU) | ||||
Teva Pharmaceutical | BUY $23→$30 | ― | -0.20% | Reiterated | Teva Pharmaceutical (TEVA) Receives a Buy from Piper Sandler | ||||
Amgen | BUY $310 | ― | -0.20% | Reiterated | Piper Sandler Reaffirms Their Buy Rating on Amgen (AMGN) | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $260 | ― | 19.10% | Assigned | ||||
Airsculpt Technologies, Inc. | HOLD $6→$5 | ― | -1.50% | Reiterated | Airsculpt Technologies, Inc. (AIRS) Gets a Hold from Piper Sandler | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $179 | ― | 12.50% | Assigned | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $11 | ― | 12.50% | Assigned | ||||
European Wax Center | HOLD $7 | ― | -1.50% | Reiterated | Piper Sandler Sticks to Their Hold Rating for European Wax Center (EWCZ) | ||||
Planet Fitness | BUY $123 | ― | -1.50% | Assigned | Piper Sandler Reaffirms Their Buy Rating on Planet Fitness (PLNT) | ||||
Enphase Energy | HOLD $70 | ― | -13.90% | Assigned | Piper Sandler Keeps Their Hold Rating on Enphase Energy (ENPH) | ||||
SolarEdge Technologies | SELL $9 | ― | -13.90% | Assigned | Piper Sandler Sticks to Its Sell Rating for SolarEdge Technologies (SEDG) | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $62 | ― | 5.50% | Assigned | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $50→$49 | ― | 10.70% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $74 | ― | 5.10% | Assigned | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $63 | ― | 8.60% | Assigned | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $58→$55 | ― | 10.70% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $37 | ― | 9.90% | Assigned | ||||
Biogen | HOLD $138 | ― | -0.20% | Reiterated | Biogen (BIIB) Receives a Hold from Piper Sandler | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $95 | ― | 3.60% | Assigned | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $40→$15 | ― | 3.20% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $53→$55 | ― | 10.70% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $54 | ― | 9.40% | Assigned | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $145→$149 | ― | 6.00% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $167→$161 | ― | 13.50% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $101→$95 | ― | 13.50% | Reiterated | ||||
xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $34 | ― | 3.10% | Reiterated |